Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Kerstan

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cytotherapy|March 18, 2019
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trialsNils Tappenbeck, Hannes M Schröder, Elke Niebergall-Roth, et al.
Cytotherapy|October 4, 2020
Ex vivo-expanded highly pure ABCB5<sup>+</sup> mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human dataAndreas Kerstan, Elke Niebergall-Roth, Jasmina Esterlechner, et al.
Stem Cell Research & Therapy|September 5, 2022
Translational development of ABCB5<sup>+</sup> dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcersAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 6, 2021
Allogeneic ABCB5<sup>+</sup> mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trialAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cytotherapy|March 18, 2019
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trialsNils Tappenbeck, Hannes M Schröder, Elke Niebergall-Roth, et al.
Cytotherapy|October 4, 2020
Ex vivo-expanded highly pure ABCB5<sup>+</sup> mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human dataAndreas Kerstan, Elke Niebergall-Roth, Jasmina Esterlechner, et al.
Stem Cell Research & Therapy|September 5, 2022
Translational development of ABCB5<sup>+</sup> dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcersAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 6, 2021
Allogeneic ABCB5<sup>+</sup> mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trialAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Pageof 6